Codes / ICD10CM / C69.50

C69.50 Malignant neoplasm of unspecified lacrimal gland and duct

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of unspecified lacrimal gland and duct

Summary

Malignant neoplasm of the unspecified lacrimal gland and duct is a rare cancer affecting the glands and ducts responsible for tear production and drainage. This condition can lead to symptoms impacting eye function and vision.

Causes

The exact causes are not fully understood, but genetic mutations and environmental factors may contribute. Some cases may be linked to prior radiation exposure or certain viral infections.

Risk Factors

  • Older age.
  • Personal or family history of cancer.
  • Exposure to radiation.
  • Significant sun damage.

Symptoms

  • Swelling around the eye.
  • Pain or discomfort.
  • Vision changes.
  • Tearing or dryness.
  • Noticeable lumps or masses near the eye.

Diagnosis

Diagnosis typically involves imaging tests such as MRI or CT scans, a thorough eye examination, and biopsy of the affected tissue to confirm malignancy.

Treatment Options

  • Surgery to remove the tumor.
  • Radiation therapy post-surgery to eradicate remaining cancer cells.
  • Chemotherapy to manage disease spread.

Prognosis and Follow-Up

Prognosis depends on factors like tumor size, stage, and response to treatment. Regular follow-up is essential to monitor for recurrence or complications.

Complications

  • Vision loss.
  • Eye pain or discomfort.
  • Spread of cancer to nearby tissue.

Lifestyle & Prevention

  • Protect the eyes from excessive sun exposure using sunglasses and hats.
  • Avoid unnecessary radiation exposure.
  • Maintain regular eye examinations, especially if at higher risk.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, persistent eye swelling, pain, or noticeable lumps near the eye.

Tips for Medical Coders

Document the absence of specification for the lacrimal gland and duct (unspecified) as this impacts code assignment. Ensure clinical documentation supports the lack of laterality or specific site details to justify the use of C69.50.

Book a walkthrough

C69.50 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.